{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:41:59Z","timestamp":1792129319600,"version":"4.4.0"},"reference-count":41,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["16\/111\/106"],"award-info":[{"award-number":["16\/111\/106"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,8,14]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Chronic lung disease of prematurity (CLD), also known as bronchopulmonary dysplasia (BPD), is a cause of significant respiratory morbidity in childhood and beyond. Coupled with lung immaturity, infections (especially by\n                      <jats:italic>Ureaplasma<\/jats:italic>\n                      spp) are implicated in the pathogenesis of CLD through promotion of pulmonary inflammation. Azithromycin, which is a highly effective against\n                      <jats:italic>Ureaplasma<\/jats:italic>\n                      spp also has potent anti-inflammatory properties. Thus, azithromycin therapy may improve respiratory outcomes by targeting infective and inflammatory pathways. Previous trials using macrolides have not been sufficiently powered to definitively assess CLD rates. To address this, the azithromycin therapy for chronic lung disease of prematurity (AZTEC) trial aims to determine if a 10-day early course of intravenous azithromycin improves rates of survival without CLD when compared with placebo with an appropriately powered study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      796 infants born at less than 30 weeks\u2019 gestational age who require at least 2 hours of continuous respiratory support within the first 72 hours following birth are being enrolled by neonatal units in the UK. They are being randomised to receive a double-blind, once daily dose of intravenous azithromycin (20 mg\/kg for 3 days, followed by 10 mg\/kg for a further 7 days), or placebo. CLD is being assessed at 36 weeks\u2019 PMA. Whether colonisation with\n                      <jats:italic>Ureaplasma<\/jats:italic>\n                      spp prior to randomisation modifies the treatment effect of azithromycin compared with placebo will also be investigated. Secondary outcomes include necrotising enterocolitis, intraventricular\/cerebral haemorrhage, retinopathy of prematurity and nosocomial infections, development of antibiotic resistance and adverse reactions will be monitored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      Ethics permission has been granted by Wales Research Ethics Committee 2 (Ref 18\/WA\/0199), and regulatory permission by the Medicines and Healthcare Products Regulatory Agency (Clinical Trials Authorisation reference 21323\/0050\/001\u20130001). The study is registered on ISRCTN (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"11650227\">ISRCTN11650227<\/jats:ext-link>\n                      ). The study is overseen by an independent Data Monitoring Committee and an independent Trial Steering Committee. We shall disseminate our findings via national and international peer-reviewed journals, and conferences. A summary of the findings will also be posted on the trial website.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041528","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:01:36Z","timestamp":1602043296000},"page":"e041528","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"isrctn11650227","registry":"10.18810\/isrctn"},{"clinical-trial-number":"isrctn11650227","registry":"10.18810\/isrctn"}],"author":[{"given":"John","family":"Lowe","sequence":"first","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gillespie","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, University Hospitals of Leicester NHS Trust, Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Child Health, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Kirby","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Pickles","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Thomas-Jones","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Turner","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Klein","sequence":"additional","affiliation":[{"name":"GOS Institute of Child Health, University College London, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R","family":"Marchesi","sequence":"additional","affiliation":[{"name":"School of Biosciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerenza","family":"Hood","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Berrington","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3535-7627","authenticated-orcid":false,"given":"Sailesh","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Child Health, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"2025121410495166000_10.10.e041528.1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2352-4642(18)30064-6","article-title":"Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study","volume":"2","author":"Simpson","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2025121410495166000_10.10.e041528.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155695","article-title":"Management of Prematurity-Associated wheeze and its association with atopy","volume":"11","author":"Edwards","year":"2016","journal-title":"PLoS One"},{"key":"2025121410495166000_10.10.e041528.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-203079"},{"key":"2025121410495166000_10.10.e041528.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60820-4"},{"key":"2025121410495166000_10.10.e041528.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.01.043"},{"key":"2025121410495166000_10.10.e041528.6","doi-asserted-by":"publisher","DOI":"10.1053\/prrv.2000.0069"},{"key":"2025121410495166000_10.10.e041528.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2010.03.002"},{"key":"2025121410495166000_10.10.e041528.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201611-2386ED"},{"key":"2025121410495166000_10.10.e041528.9","doi-asserted-by":"publisher","DOI":"10.1136\/fn.72.2.F90"},{"key":"2025121410495166000_10.10.e041528.10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.qco.0000224819.42729.2e","article-title":"Antenatal infection and inflammation: what's new?","volume":"19","author":"Maxwell","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"2025121410495166000_10.10.e041528.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2008.11.009"},{"key":"2025121410495166000_10.10.e041528.12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000239"},{"key":"2025121410495166000_10.10.e041528.13","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1055\/s-0039-1691802","article-title":"Update on postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia","volume":"36","author":"Filippone","year":"2019","journal-title":"Am J Perinatol"},{"key":"2025121410495166000_10.10.e041528.14","first-page":"CD003744","article-title":"Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum","volume":"4","author":"Mabanta","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121410495166000_10.10.e041528.15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-1350"},{"key":"2025121410495166000_10.10.e041528.16","doi-asserted-by":"publisher","DOI":"10.4065\/74.6.613"},{"key":"2025121410495166000_10.10.e041528.17","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e318142582d"},{"key":"2025121410495166000_10.10.e041528.18","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.81"},{"key":"2025121410495166000_10.10.e041528.19","doi-asserted-by":"publisher","DOI":"10.1159\/000363493"},{"key":"2025121410495166000_10.10.e041528.20","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010382021"},{"key":"2025121410495166000_10.10.e041528.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03951-14"},{"key":"2025121410495166000_10.10.e041528.22","unstructured":"Viscardi RM , Terrin ML , Magder LS , et al . Randomised trial of azithromycin to in preterm infants. Archives of Disease in Childhood - Fetal and Neonatal Edition 2020:fetalneonatal-2019-318122."},{"key":"2025121410495166000_10.10.e041528.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008194"},{"key":"2025121410495166000_10.10.e041528.24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00889-15"},{"key":"2025121410495166000_10.10.e041528.25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01909-2019","article-title":"Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants","volume":"55","author":"Gallacher","year":"2020","journal-title":"Eur Respir J"},{"key":"2025121410495166000_10.10.e041528.26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jemermed.2015.09.017","article-title":"Commentary on reconstituting fibrinogen concentrate to maintain blinding in a double-blind, randomized trial in an emergency setting","volume":"50","author":"Bruynseels","year":"2016","journal-title":"J Emerg Med"},{"key":"2025121410495166000_10.10.e041528.27","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.2011060"},{"key":"2025121410495166000_10.10.e041528.28","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.095406"},{"key":"2025121410495166000_10.10.e041528.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514212"},{"key":"2025121410495166000_10.10.e041528.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.15.1987"},{"key":"2025121410495166000_10.10.e041528.31","unstructured":"International Council for Harmonisation . ICH E9: statistical principles for clinical trials, step 5 1998, 2020. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-9-statistical-principles-clinical-trials-step-5_en.pdf [Accessed 17 Apr 2020]."},{"key":"2025121410495166000_10.10.e041528.32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.4.e45"},{"key":"2025121410495166000_10.10.e041528.33","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06625-11"},{"key":"2025121410495166000_10.10.e041528.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03217.x"},{"key":"2025121410495166000_10.10.e041528.35","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.195180"},{"key":"2025121410495166000_10.10.e041528.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2008.12.002"},{"key":"2025121410495166000_10.10.e041528.37","doi-asserted-by":"crossref","DOI":"10.1038\/srep04076","article-title":"Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey","volume":"4","author":"Pansieri","year":"2014","journal-title":"Sci Rep"},{"key":"2025121410495166000_10.10.e041528.38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(13)70118-8","article-title":"Early lung development: lifelong effect on respiratory health and disease","volume":"1","author":"Stocks","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2025121410495166000_10.10.e041528.39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00788-2019","article-title":"European respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia","volume":"55","author":"Duijts","year":"2020","journal-title":"Eur Respir J"},{"key":"2025121410495166000_10.10.e041528.40","doi-asserted-by":"crossref","unstructured":"Lowe J , Kotecha SJ , Kotecha S . Long Term Effects Following Extreme Prematurity: Respiratory Problems. In: Boyle EM , Cusack J , eds. Emerging topics and controversies in neonatology. Switzerland: Springer, 2020: 351\u201366.","DOI":"10.1007\/978-3-030-28829-7_20"},{"key":"2025121410495166000_10.10.e041528.41","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/cid\/ciz893","article-title":"Antimicrobial resistance following azithromycin mass drug administration: potential surveillance strategies to assess public health impact","volume":"70","author":"Mack","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:50:01Z","timestamp":1765738201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,6]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bmjopen-2020-041528"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041528","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}